Our CEO and founder, Matt Cantelo recently met with the editor of the local newspaper, The Northern Daily Leader to discuss ANTG’s partnership with Cannamedical Pharma, a German pharmaceutical company, and its plans for growth, including the opening of their new facility in Armidale. Read the article here.
ANTG has listed two new THC-dominant medicinal cannabis strains on the Australian Register of Therapeutic Goods (ARTG).
In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.LEARN ABOUT ANTG HERE >